RxDoctor Payments Data

John Pesando

Hematology & Oncology · Seattle, WANPI 1477150969

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $15,676,499 of the $15,676,499 with a category attached, or 100.0%. Beckman Coulter, Inc. accounts for 96.1% of it on its own, with 1 other manufacturer making up the rest. Among hematology & oncology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,676,499in general payments, 2019–2025

Across 101 payments — averaging $155,213 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Beckman Coulter, Inc.$15.1M
  • BD$608K

What the payments were for

  • Royalty or licence$15,676,499100%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Beckman Coulter, Inc.12$15,068,170
BD89$608,328

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,676,499 in reported general payments places this provider in the 95th percentile of 349 hematology & oncology providers in Washington.

See all hematology & oncology providers in Washington

Other hematology & oncology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →